Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 599

1.

Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysis.

Zheng D, Xu Y, You S, Hackett ML, Woodman RJ, Li Q, Woodward M, Loffler KA, Rodgers A, Drager LF, Lorenzi-Filho G, Wang X, Quan WW, Tripathi M, Mediano O, Ou Q, Chen R, Liu Z, Zhang X, Luo Y, McArdle N, Mukherjee S, McEvoy RD, Anderson CS.

EClinicalMedicine. 2019 Jun 13;11:89-96. doi: 10.1016/j.eclinm.2019.05.012. eCollection 2019 May-Jun.

PMID:
31312807
2.

Evaluating the prevalence and quality of conference codes of conduct.

Foxx AJ, Barak RS, Lichtenberger TM, Richardson LK, Rodgers AJ, Webb Williams E.

Proc Natl Acad Sci U S A. 2019 Jul 8. pii: 201819409. doi: 10.1073/pnas.1819409116. [Epub ahead of print]

PMID:
31285334
3.

Rodent species as possible reservoirs of Borrelia burgdorferi in a prairie ecosystem.

Beckmann S, Freund R, Pehl H, Rodgers A, Venegas T.

Ticks Tick Borne Dis. 2019 Jun 13. pii: S1877-959X(18)30497-7. doi: 10.1016/j.ttbdis.2019.06.011. [Epub ahead of print]

PMID:
31248821
4.

Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States.

Gaziano TA, Pandya A, Sy S, Jardim TV, Ogden JM, Rodgers A, Weinstein MC.

Am Heart J. 2019 May 7;214:77-87. doi: 10.1016/j.ahj.2019.04.020. [Epub ahead of print]

PMID:
31174054
5.

Does Co-administration of Antihypertensive Drugs and Statins Alter Their Efficacy and Safety? A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Kanukula R, Esam H, Sundström J, Rodgers A, Salam A.

J Cardiovasc Pharmacol. 2019 Jun;73(6):352-358. doi: 10.1097/FJC.0000000000000671.

PMID:
31162243
6.

Theoretical and laboratory investigations of the effects of hydroxyproline ingestion on the metabolic and physicochemical risk factors for calcium oxalate kidney stone formation in a small group of healthy subjects.

Rodgers A, Cele P, Ravenscroft N, Edmonds-Smith C, Jackson G.

Int Urol Nephrol. 2019 Jul;51(7):1121-1127. doi: 10.1007/s11255-019-02186-2. Epub 2019 Jun 3.

PMID:
31161522
7.

Once-Daily Doravirine in HIV-1-Infected, Antiretroviral-Naive Adults: An Integrated Efficacy Analysis.

Orkin C, Molina JM, Lombaard J, DeJesus E, Rodgers A, Kumar S, Martin E, Hanna G, Hwang C.

Clin Infect Dis. 2019 May 23. pii: ciz424. doi: 10.1093/cid/ciz424. [Epub ahead of print]

PMID:
31121015
8.

Once-Daily Doravirine for Initial Treatment of Adults Living With HIV-1: An Integrated Safety Analysis.

Thompson M, Orkin C, Molina JM, Sax P, Cahn P, Squires K, Xu X, Rodgers A, Kumar S, Teppler H, Martin E, Hanna G, Hwang C.

Clin Infect Dis. 2019 May 23. pii: ciz423. doi: 10.1093/cid/ciz423. [Epub ahead of print]

PMID:
31121013
9.

Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials.

Salam A, Atkins ER, Hsu B, Webster R, Patel A, Rodgers A.

J Hypertens. 2019 Aug;37(8):1567-1573. doi: 10.1097/HJH.0000000000002089.

PMID:
31058799
10.

HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration.

Voss SR, Ponomareva LV, Dwaraka VB, Pardue KE, Baddar NWAH, Rodgers AK, Woodcock MR, Qiu Q, Crowner A, Blichmann D, Khatri S, Thorson JS.

Sci Rep. 2019 May 1;9(1):6751. doi: 10.1038/s41598-019-43230-6.

11.

Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.

Rahman F, McEvoy JW, Ohkuma T, Marre M, Hamet P, Harrap S, Mancia G, Rodgers A, Selvin E, Williams B, Muntner P, Chalmers J, Woodward M.

Hypertension. 2019 Jun;73(6):1291-1299. doi: 10.1161/HYPERTENSIONAHA.118.12414.

PMID:
31030606
12.

Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials.

Salam A, Kanukula R, Atkins E, Wang X, Islam S, Kishore SP, Jaffe MG, Patel A, Rodgers A.

J Hypertens. 2019 Apr 9. doi: 10.1097/HJH.0000000000002096. [Epub ahead of print]

PMID:
30986788
13.

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials.

Pinho-Gomes AC, Azevedo L, Bidel Z, Nazarzadeh M, Canoy D, Copland E, Salam A, Rodgers A, Kotecha D, Rahimi K.

J Hypertens. 2019 Apr 3. doi: 10.1097/HJH.0000000000002094. [Epub ahead of print]

PMID:
30950980
14.

Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm Hg.

Salam A, Rodgers A.

J Clin Hypertens (Greenwich). 2019 May;21(5):689. doi: 10.1111/jch.13522. Epub 2019 Mar 24. No abstract available.

15.

Control of Klebsiella pneumoniae Infection in Mice by Using Dissolving Microarray Patches Containing Gentamicin.

Rodgers AM, McCrudden MTC, Courtenay AJ, Kearney MC, Edwards KL, Ingram RJ, Bengoechea J, Donnelly RF.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02612-18. doi: 10.1128/AAC.02612-18. Print 2019 May.

16.

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study.

Jun M, Jardine MJ, Perkovic V, Pilard Q, Billot L, Rodgers A, Rogers K, Gallagher M.

PLoS One. 2019 Mar 7;14(3):e0213192. doi: 10.1371/journal.pone.0213192. eCollection 2019.

17.

Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial.

Shariful Islam SM, Chow CK, Redfern J, Kok C, Rådholm K, Stepien S, Rodgers A, Hackett ML.

BMJ Open. 2019 Feb 20;9(2):e022637. doi: 10.1136/bmjopen-2018-022637.

18.

A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trial.

Gálvez Ortiz V, Glue P, Somogyi AA, Martin D, Alonzo A, Rodgers A, Mitchell PB, Li A, Huggins C, Loo CK.

J Psychopharmacol. 2019 Feb;33(2):260-261. doi: 10.1177/0269881118822147. No abstract available.

PMID:
30773113
19.

Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

Fakier S, Rodgers A, Jackson G.

Urolithiasis. 2019 Feb 14. doi: 10.1007/s00240-019-01117-1. [Epub ahead of print]

PMID:
30767040
21.
22.

Uncertainty analysis for infrasound waveform inversion: Application to explosion yield estimation.

Kim K, Rodgers A, Wright M.

J Acoust Soc Am. 2018 Dec;144(6):3351. doi: 10.1121/1.5082549.

PMID:
30599684
23.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

24.

Feasibility and potential efficacy of commercial mHealth/eHealth tools for weight loss in African American breast cancer survivors: pilot randomized controlled trial.

Ferrante JM, Devine KA, Bator A, Rodgers A, Ohman-Strickland PA, Bandera EV, Hwang KO.

Transl Behav Med. 2018 Dec 9. doi: 10.1093/tbm/iby124. [Epub ahead of print]

PMID:
30535101
25.

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.

Nachman S, Alvero C, Teppler H, Homony B, Rodgers AJ, Graham BL, Fenton T, Frenkel LM, Browning RS, Hazra R, Wiznia AA; IMPAACT 1066 study team.

Lancet HIV. 2018 Dec;5(12):e715-e722. doi: 10.1016/S2352-3018(18)30257-1.

26.

Regression to the mean of repeated ambulatory blood pressure monitoring in five studies.

Moore MN, Atkins ER, Salam A, Callisaya ML, Hare JL, Marwick TH, Nelson MR, Wright L, Sharman JE, Rodgers A.

J Hypertens. 2019 Jan;37(1):24-29. doi: 10.1097/HJH.0000000000001977.

PMID:
30499921
27.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
28.

Novel Hydrogel-Forming Microneedle Array for Intradermal Vaccination in Mice Using Ovalbumin as a Model Protein Antigen.

Courtenay AJ, Rodgers AM, McCrudden MTC, McCarthy HO, Donnelly RF.

Mol Pharm. 2019 Jan 7;16(1):118-127. doi: 10.1021/acs.molpharmaceut.8b00895. Epub 2018 Nov 27.

PMID:
30452868
29.

Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India.

Praveen D, Peiris D, MacMahon S, Mogulluru K, Raghu A, Rodgers A, Chilappagari S, Prabhakaran D, Clifford GD, Maulik PK, Atkins E, Joshi R, Heritier S, Jan S, Patel A.

BMC Public Health. 2018 Nov 15;18(1):1264. doi: 10.1186/s12889-018-6142-x.

30.

Report of the proceedings of a UK skin safety advisory group.

Browning P, Beeckman D, White R, Connolly R, Rodgers A, Maclean G, Fumarola S, Harker J, Murray V, Foster S.

Br J Nurs. 2018 Nov 8;27(20):S34-S40. doi: 10.12968/bjon.2018.27.Sup20.S34.

PMID:
30418847
31.

Vision for the future on urolithiasis: research, management, education and training-some personal views.

Rodgers A, Trinchieri A, Ather MH, Buchholz N; U-Merge Scientific Office.

Urolithiasis. 2018 Oct 29. doi: 10.1007/s00240-018-1086-2. [Epub ahead of print] Review.

PMID:
30374670
32.

Options in bariatric surgery: modeled decision analysis supports Roux-en-Y gastric bypass and sleeve gastrectomy as the treatments of choice.

Keogh S, Bolger JC, Brady S, Rodgers A, Arumugasamy M, Robb WB.

Surg Obes Relat Dis. 2018 Nov;14(11):1670-1677. doi: 10.1016/j.soard.2018.08.004. Epub 2018 Aug 23.

PMID:
30268362
33.

Fixed-dose combinations for hypertension.

Kishore SP, Salam A, Rodgers A, Jaffe MG, Frieden T.

Lancet. 2018 Sep 8;392(10150):819-820. doi: 10.1016/S0140-6736(18)31814-2. No abstract available.

PMID:
30215377
34.

Dissolving microneedles for intradermal vaccination: manufacture, formulation, and stakeholder considerations.

Rodgers AM, Courtenay AJ, Donnelly RF.

Expert Opin Drug Deliv. 2018 Nov;15(11):1039-1043. doi: 10.1080/17425247.2018.1522301. Epub 2018 Sep 19. No abstract available.

PMID:
30204003
35.

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.

Orkin C, Squires KE, Molina JM, Sax PE, Wong WW, Sussmann O, Kaplan R, Lupinacci L, Rodgers A, Xu X, Lin G, Kumar S, Sklar P, Nguyen BY, Hanna GJ, Hwang C, Martin EA; DRIVE-AHEAD Study Group.

Clin Infect Dis. 2019 Feb 1;68(4):535-544. doi: 10.1093/cid/ciy540.

36.

Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.

Webster R, Salam A, de Silva HA, Selak V, Stepien S, Rajapakse S, Amarasekara S, Amarasena N, Billot L, de Silva AP, Fernando M, Guggilla R, Jan S, Jayawardena J, Maulik PK, Mendis S, Mendis S, Munasinghe J, Naik N, Prabhakaran D, Ranasinghe G, Thom S, Tisserra N, Senaratne V, Wijekoon S, Wijeyasingam S, Rodgers A, Patel A; TRIUMPH Study Group.

JAMA. 2018 Aug 14;320(6):566-579. doi: 10.1001/jama.2018.10359. Erratum in: JAMA. 2018 Nov 13;320(18):1940.

37.

Real-Time in Vivo Photoacoustic Imaging in the Assessment of Myocardial Dynamics in Murine Model of Myocardial Ischemia.

Mukaddim RA, Rodgers A, Hacker TA, Heinmiller A, Varghese T.

Ultrasound Med Biol. 2018 Oct;44(10):2155-2164. doi: 10.1016/j.ultrasmedbio.2018.05.021. Epub 2018 Jul 29.

PMID:
30064849
38.

Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.

Rodgers AM, Cordeiro AS, Kissenpfennig A, Donnelly RF.

Expert Opin Drug Deliv. 2018 Sep;15(9):851-867. doi: 10.1080/17425247.2018.1505860. Epub 2018 Aug 1. Review.

PMID:
30051726
39.

Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept study.

Rodgers AM, McCrudden MTC, Vincente-Perez EM, Dubois AV, Ingram RJ, Larrañeta E, Kissenpfennig A, Donnelly RF.

Int J Pharm. 2018 Oct 5;549(1-2):87-95. doi: 10.1016/j.ijpharm.2018.07.049. Epub 2018 Jul 23.

40.

Testing the dogma that total phospholipid fatty acid composition of blood plays a role in kidney stone pathogenesis, using a high-low risk human model: results from a pilot study.

Rodgers AL, Jappie-Mahomed D, van Jaarsveld PJ.

Urolithiasis. 2019 Jun;47(3):255-261. doi: 10.1007/s00240-018-1071-9. Epub 2018 Jun 29. Erratum in: Urolithiasis. 2019 Jan 8;:.

PMID:
29959478
41.

Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials.

Selak V, Webster R, Stepien S, Bullen C, Patel A, Thom S, Arroll B, Bots ML, Brown A, Crengle S, Dorairaj P, Elley CR, Grobbee DE, Harwood M, Hillis GS, Laba TL, Neal B, Peiris D, Rafter N, Reid C, Stanton A, Tonkin A, Usherwood T, Wadham A, Rodgers A.

Heart. 2019 Jan;105(1):42-48. doi: 10.1136/heartjnl-2018-313108. Epub 2018 Jun 28.

42.

Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.

Ferraro PM, Ticinesi A, Meschi T, Rodgers A, Di Maio F, Fulignati P, Borghi L, Gambaro G.

J Urol. 2018 Nov;200(5):1082-1087. doi: 10.1016/j.juro.2018.06.029. Epub 2018 Jun 22.

PMID:
29940247
43.

Woodland caribou habitat selection patterns in relation to predation risk and forage abundance depend on reproductive state.

Viejou R, Avgar T, Brown GS, Patterson BR, Reid DEB, Rodgers AR, Shuter J, Thompson ID, Fryxell JM.

Ecol Evol. 2018 May 4;8(11):5863-5872. doi: 10.1002/ece3.4124. eCollection 2018 Jun.

44.

Response to 'SPRINT in context: meta-analysis of trials with baseline normotension and low levels of previous cardiovascular disease'.

Salam A, Atkins E, Rodgers A.

J Hypertens. 2018 Jul;36(7):1602-1603. doi: 10.1097/HJH.0000000000001758. No abstract available.

PMID:
29847452
45.

LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages.

Härtlova A, Herbst S, Peltier J, Rodgers A, Bilkei-Gorzo O, Fearns A, Dill BD, Lee H, Flynn R, Cowley SA, Davies P, Lewis PA, Ganley IG, Martinez J, Alessi DR, Reith AD, Trost M, Gutierrez MG.

EMBO J. 2018 Jun 15;37(12). pii: e98694. doi: 10.15252/embj.201798694. Epub 2018 May 22.

46.

Mass, height of burst, and source-receiver distance constraints on the acoustic coda phase delay method.

Albert S, Bowman D, Rodgers A, Seastrand D.

J Acoust Soc Am. 2018 Apr;143(4):2332. doi: 10.1121/1.5032216.

PMID:
29716266
47.

Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial.

Singh K, Crossan C, Laba TL, Roy A, Hayes A, Salam A, Jan S, Lord J, Tandon N, Rodgers A, Patel A, Thom S, Prabhakaran D.

Int J Cardiol. 2018 Jul 1;262:71-78. doi: 10.1016/j.ijcard.2018.03.082. Epub 2018 Mar 21.

48.

False reassurance about the consequences of withdrawing antihypertensive drug therapy.

Salam A, Rodgers A.

J Hypertens. 2018 Feb;36(2):447-448. doi: 10.1097/HJH.0000000000001616. No abstract available.

PMID:
29611839
49.

Questionable Conclusions Regarding Blood Pressure End Points.

Rodgers A, Atkins E, Salam A.

JAMA Intern Med. 2018 Apr 1;178(4):575. doi: 10.1001/jamainternmed.2018.0340. No abstract available.

PMID:
29610880
50.

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.

Molina JM, Squires K, Sax PE, Cahn P, Lombaard J, DeJesus E, Lai MT, Xu X, Rodgers A, Lupinacci L, Kumar S, Sklar P, Nguyen BY, Hanna GJ, Hwang C; DRIVE-FORWARD Study Group.

Lancet HIV. 2018 May;5(5):e211-e220. doi: 10.1016/S2352-3018(18)30021-3. Epub 2018 Mar 25.

PMID:
29592840

Supplemental Content

Loading ...
Support Center